Company intelligence / Profile preview
Scribe Therapeutics
Alameda, California, USAscribetx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Developing CRISPR-based therapeutics with improved safety and efficacy profiles. Their X-Editor platform shows 100x improvements in activity with no detectable off-target editing[4].
- Therapeutic areas
- OncologyCardiovascularNeurology
- Modalities
- CRISPR-based gene editing therapeutics
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
BiogenSanofi[5]
Beyond the preview
Go deeper on Scribe Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scribe Therapeutics.